TCGA-LIHC database analysis showed that the selected 33 DEIRGs have a lower mutation rate in HCC patients, in which only SAA1 mutation significantly co-occurred with TP53 mutation. This evidence concerns the gene SAA1 and hepatocellular carcinoma.